Guardant Health, Inc.
NASDAQ: GH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Helmy Eltoukhy
- Employees
- 1,999
- Headquarters
- Palo Alto, United States
- IPO year
- 2018
- Market cap
- $17.5B
- Website
- https://guardanthealth.com
Loading GH…
Loading profile data…Frequently asked questions about GH
What does Guardant Health, Inc. (GH) do?
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include sever...
Where does GH trade?
Guardant Health, Inc. (GH) trades on the NASDAQ Global Select.
What sector is GH in?
Guardant Health, Inc. (GH) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Guardant Health, Inc.?
Helmy Eltoukhy is the chief executive officer of Guardant Health, Inc. (GH).
Where is Guardant Health, Inc. headquartered?
Guardant Health, Inc. is headquartered in United States.
Does GH pay a dividend?
Guardant Health, Inc. (GH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GH go public?
Guardant Health, Inc. (GH) completed its initial public offering in 2018.